Parecer de pré-exame
#6.23
08/18/2026
RPI 2902
Application data
Number
112022014058Type
Filing
Publication
PCT
US2021013883 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 08/18/2026. We update with every new RPI gazette, published weekly.
Applicants
G. C. (pessoa física)
US
PRINCIPIA BIOPHARMA INC.
US
Inventors
E. W. (pessoa física)
US
M. C. (pessoa física)
US
T. T. (pessoa física)
US
IPC Classification
Priority claims
US
62/963,238 · 01/20/2020
US
62/970,502 · 02/05/2020
US
63/013,895 · 04/22/2020
Abstract
INIBIDORES TERAPÊUTICOS DE TIROSINA CINASE PARA ESCLEROSE MÚLTIPLA RECIDIVANTE (RMS). A presente invenção refere-se ao campo de inibidores de tirosina cinase terapêuticos, em particular, inibidores de tirosina cinase de Bruton ("BTK") para tratamento de indivíduos com esclerose múltipla recidivante.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
08/18/2026
RPI 2902
#25.7
12/23/2025
RPI 2868
#25.1
12/09/2025
RPI 2866
#1.3
09/13/2022
RPI 2697
#1.1
07/26/2022
RPI 2690
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.